PortfolioCambium Biomaterials
Advanced MaterialsFund I
Cambium Biomaterials logo

Cambium Biomaterials

Computational material discovery to production

Advanced materials innovator for defense. One-stop shop for vertically-integrated innovation, from computational material discovery through to production of advanced composites.

At a Glance
HeadquartersEl Segundo, CA
Latest MilestoneJan 2026: Closed $100M Series B led by 8VC with Lockheed Martin Ventures
Veteran LeadersSimon Waddington, Stephan Herrera

Quick Facts

SectorAdvanced Materials
VVC FundFund I
HeadquartersEl Segundo, CA
StatusActive
Sector Context

Why Advanced Materials matters.

Advanced materials are critical enablers across defense platforms — from hypersonics to body armor. The defense composites market is projected to exceed $20B by 2030.

Leadership Team
Simon WaddingtonCo-Founder & CEO
Veteran

British Army veteran, Brigadier General (retired), Mechanical Engineer

Stephan HerreraCo-Founder & CMO
Veteran

U.S. Air Force veteran, Senior Executive Service

James GriffinCTO

20 years in advanced materials, PhD in Chemical Engineering

Key Milestones
Jan 2026: Closed $100M Series B led by 8VC with Lockheed Martin VenturesSource
Dec 2025: Acquired SHD Group, global advanced composites manufacturerSource
Nov 2025: Awarded DARPA contract for AI-driven extreme-temperature materialsSource
Apr 2025: Launched ApexShield resin system reducing hypersonic parts fabrication timeSource
Apr 2025: Contracted with U.S. Navy for hypersonic thermal protection systemsSource
Mar 2026: Awarded U.S. government counter-laser and directed energy contractSource